NewAmsterdam Pharma Company N.V.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $347.1M
Liabilities Breakdown FY2023
Total Liabilities: $58.7M
Asset Breakdown
Total Assets: $347.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $340.5M | 98.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $46.0K | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $6.6M | 1.9% |
Liabilities Breakdown
Total Liabilities: $58.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $16.9M | 28.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $41.8M | 71.2% |